Tradestie Institutional Equity Comparison Engine

CRL vs GRAL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRL Overall Edge

CRL Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Charles River Laboratories International, Inc. (CRL) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while GRAL counters with relative strength in Valuation. Fundamentally, CRL trades at 25.9x Forward P/E with 14.3% operating margin (-2.2% YoY revenue) versus GRAL at 1.1x Forward P/E and -332.0% operating margin (+3.7% YoY). In options structure, CRL sits in UNCLASSIFIED (11th %ile IV; Dealer Gamma Walls on Pro) against GRAL sits in BREAKDOWN (53rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GRAL
CRL 25.9x vs GRAL 1.1x Fwd P/E
Growth & Margin Winner CRL
Op Margin 14.3% vs -332.0% ยท YoY -2.2% vs +3.7%
Momentum & Technical Winner CRL
1Y +98.3% vs +24.6% ยท 52W Pos 81% vs 51%
Options & Structure Winner CRL
UNCLASSIFIED (11th %ile IV) vs BREAKDOWN (53rd %ile IV)
CRL NYSE
Charles River Laboratories International, Inc.
Services-Commercial Physical & Biological Research
$335.52
-0.72% 1D
Market Cap $16.2B
1M Return +11.78%
1Y Return +98.29%
Forward P/E 25.9x
Unified AI Score
48.0 / 100 HOLD
Tech 39.0 Fund 39.0 Flow 50.0 Mom 25.9
GRAL NASDAQ
GRAIL, Inc. Common Stock
Services-Medical Laboratories
$105.60
-8.88% 1D
Market Cap $5.2B
1M Return -10.36%
1Y Return +24.57%
Forward P/E 1.1x
Unified AI Score
54.5 / 100 HOLD
Tech 35.0 Fund 49.0 Flow 57.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRL +98.29% GRAL +24.57% Spread: +71.37 pp (CRL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CRL TTM Op. Margin: 14.3% GRAL TTM Op. Margin: -332.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CRL vs GRAL. Trailing 12-month operating profitability (CRL 14.3% vs GRAL -332.0%) and valuation multiples (CRL 25.9x vs GRAL 1.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRL (6) vs GRAL (4)
Institutional Metric CRL GRAL Criterion Row Winner
Market Capitalization Scale $16.2B $5.2B Larger Scale CRL
Trailing P/E Ratio Valuation N/M 1.1x Lower Multiple GRAL
Forward P/E Ratio Valuation 25.9x 1.1x Lower Multiple GRAL
Revenue Growth (YoY) Growth -2.2% +3.7% Higher Growth GRAL
Operating Margin (TTM) Profitability 14.3% -332.0% Higher Margin CRL
Net Profit Margin Profitability 1.0% -243.8% Higher Margin CRL
Return on Equity (ROE) Capital Efficiency 1.3% -17.3% Higher ROE CRL
52-Week Range Position Momentum 81% ($146โ€“$380) 51% ($42โ€“$166) Stronger Trend CRL
Beta / 30D Volatility Risk Regime 1.09ฮฒ ยท 68% Vol 3.09ฮฒ ยท 99% Vol Lower Realized Risk CRL
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 54.5 / 100 (HOLD) Higher Composite GRAL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRL vs GRAL Buy Guide
CRL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live CRL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GRAL BREAKDOWN
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live GRAL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRL nor GRAL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.